Filter Results:
(185)
Show Results For
- All HBS Web
(185)
- People (1)
- News (53)
- Research (84)
- Events (3)
- Multimedia (8)
- Faculty Publications (54)
Show Results For
- All HBS Web
(185)
- People (1)
- News (53)
- Research (84)
- Events (3)
- Multimedia (8)
- Faculty Publications (54)
- 09 Feb 2016
- First Look
February 9, 2016
a proxy contest and a special shareholder meeting to vote on replacing Allergan's directors with a slate more favorable to the Valeant merger. The proposed Salix acquisition would give Allergan a new therapeutic market but would also make... View Details
Keywords: Sean Silverthorne
- 01 Feb 1997
- News
Shaping the Future of Business: Entrepreneurial Evolution at HBS
a thriving organization of significant scale. Gordon M. Binder (MBA '62) played a key role in just such a transition at Amgen, which now ranks as the largest biotechnology firm in the world. A California-based firm that discovers, develops, manufactures, and markets... View Details
- 18 Nov 2014
- First Look
First Look: November 18
the continuing battle affect management, talent, and the company's financial performance? Purchase this case: https://hbr.org/product/Turkcell/an/715009-PDF-ENG Harvard Business School Case 615-024 Pfizer's Centers for Therapeutic... View Details
Keywords: Sean Silverthorne
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
drugs (chemically-synthesized, “small-molecule” drugs) face price competition from generic drugs after patent expiration, biosimilars—biologic drugs that have been shown to be therapeutically equivalent to an already approved original... View Details
Keywords: Sean Silverthorne
- 26 Nov 2013
- First Look
First Look: November 26
Beshears, John, James J. Choi, David Laibson, Brigitte C. Madrian, and Gwendolyn Reynolds Abstract—Objectives: To assess whether the addition of a peer testimonial to an informational mailing increases conversion rates from brand name prescription medications to... View Details
Keywords: Sean Silverthorne
- 08 Jun 2010
- First Look
First Look: June 8
uncertainty of commercial partners' interest in the therapeutic approach, and the constrained donor-based fundraising environment. Purchase this case:http://cb.hbsp.harvard.edu/cb/product/610074-PDF-ENG Data.gov Karim R. Lakhani, Robert... View Details
Keywords: Martha Lagace
- 23 Mar 2021
- Book
Succeeding in the New Work-from-Anywhere World
than fifty years, self-disclosure has been widely studied across a variety of interpersonal contexts, including friendships, romances, and therapeutic relations. The way to enhance trust between people is for all parties to self-disclose,... View Details
Keywords: by Michael Blanding
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
"But in order to determine that genetic information has a therapeutic use, we have to make a substantial investment—$350 to $500 million—in doing the clinical trial work. From a business standpoint, we need to protect our... View Details
- 01 Dec 2013
- News
Curing Health Care
products. Stock predicts that the development pace for personalized therapeutics and preventive diagnostics will pick up speed, thanks to the beneficial add-on effects derived from identifying more and more biomarkers for particular... View Details
- 14 May 2020
- Research & Ideas
What Leaders Can Do to Fight the COVID Fog
well (and no one is there to watch you). Exercise is also an area where individuals have a great deal of control, which makes it a therapeutic activity in times of uncertainty. Short-term bursts of strenuous activity are not only... View Details
Keywords: by Boris Groysberg and Robin Abrahams
- 20 Sep 2016
- First Look
September 20, 2016
since it was started, with no therapeutic product available in the foreseeable future, Kaplan is considering whether it is time to change the company's business model. Purchase this case:... View Details
Keywords: Sean Silverthorne
- 11 Apr 2017
- First Look
First Look at New Research, April 11
treated with unproductive therapies while more easily uncovering therapeutic signals. However, such research initiatives alone will not deliver new medicines to patients in the absence of strong incentives to bring new products to market.... View Details
- Web
Annual Report 2019 - Annual Report 2019
Therapeutics Extracorporeal CO 2 removal device that uses ultra-low blood flow to treat patients with hypercarbic respiratory failure. 266 Teams 200 Judges $ 315,000 Cash Prizes See press release MS/MBA in Biotechnology: Life Sciences In... View Details
- 15 Jan 2019
- First Look
New Research and Ideas, January 15, 2019
forthcoming American Journal of Therapeutics Food and Drug Administration Guidance Documents and New Medical Devices: The Case of Breast Prostheses By: Weitzman, Rachel E., Ariel Dora Stern, and Daniel B. Kramer Abstract—No abstract... View Details
Keywords: Dina Gerdeman
- 28 Apr 2009
- First Look
First Look: April 28, 2009
Industry Location and International Regulatory Variation Author:Arthur A. Daemmrich Publication:Chap. 16 in Ways of Regulating: Therapeutic Agents between Plants, Shops, and Consulting Rooms. Vol. 363, 271-290. Berlin, Germany: Max Planck... View Details
Keywords: Martha Lagace
- Web
Print View - Course Catalog
like Verve Therapeutics announced the first human trials of a single shot cure for all heart attacks through a one-time change in a single gene. In most of these cases, business choices like market selection, financing strategy and... View Details